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Abstract
Background: Fetal nutritional insults may alter the later metabolic phenotype. We hypothe-
sized that early timing of prenatal food supplementation and multiple micronutrient supple-
mentation (MMS) would favourably influence childhood metabolic phenotype.
Methods: Pregnant women recruited 1 January to 31 December 2002 in Matlab,
Bangladesh, were randomized into supplementation with capsules of either 30mg of
iron and 400 lg of folic acid, 60mg of iron and 400 lg of folic acid, or MMS containing a
daily allowance of 15 micronutrients, and randomized to food supplementation (608 kcal)
either with early invitation (9 weeks’ gestation) or usual invitation (at 20 weeks). Their
children (n¼1667) were followed up at 4.5 years with assessment of biomarkers of lipid
and glucose metabolism, inflammation and oxidative stress.
Results: Children in the group with early timing of food supplementation had lower chol-
esterol (difference -0.079mmol/l, 95% confidence interval (CI) -0.156; -0.003), low-density
lipoprotein (LDL) (difference -0.068mmol/l, 95% CI -0.126; -0.011) and ApoB levels (differ-
ence -0.017 g/l, 95% CL -0.033; -0.001). MMS supplementation resulted in lower high-
density lipoprotein (HDL) (difference -0.028mmol/l, 95% CL -0.053; -0.002), lower glucose
(difference -0.099mmol/l, 95% CL -0.179; -0.019) and lower insulin-like growth factor 1
(IGF-1) (difference on log scale -0.141 mg/l, 95% CL -0.254; -0.028) than 60mg iron and 400
lg folic acid. There were no effects on markers of inflammation or oxidative stress.
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Original article
Conclusions: Findings suggest that in a population where malnutrition is prevalent, nutri-
tion interventions during pregnancy may modify the metabolic phenotype in the young
child that could have consequences for later chronic disease risks.
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Introduction
Nutritional imbalance in fetal life and a small size at birth
are associated with serious short-term consequences, such
as increased neonatal and infant mortality,1 and impaired
child growth,2 as well as with long-term health conse-
quences highlighted in the Developmental Origins of
Health and Disease (DOHaD) hypothesis.3 Limitations in
nutrition during fetal life and early infancy, when plasticity
is great, result in developmental adaptations inducing per-
manent changes in the metabolic phenotype. This increases
the risk for insulin resistance,4 hyperlipidaemia,5 hyperten-
sion6 and non-communicable diseases in adulthood such as
type 2 diabetes7 and coronary heart disease.8 Different
mechanisms underlying these effects have been proposed,
such as structural changes in critical organs, epigenetic
programming9 and oxidative stress,10 to name but a few. It
is implicit that improved nutrition in early life may have
the potential to reduce or prevent both short- and long-
term health consequences of fetal and early life
undernutrition.
Systematic reviews of the relative limited number of
conducted trials providing balanced energy protein supple-
ments in pregnancy show reduction in the frequency of
stillbirth, increased birthweight and reduced occurrence of
small-for-gestational-age.11 Only a few of these studies
have assessed metabolic markers in the offspring in child-
hood, adolescence or beyond. In Guatemala, an analysis
was performed of adults born in villages where the popula-
tion (including mothers and children) received a protein-
energy supplement across different time periods from
conception to 72 months of age. The adults with mothers
who received the supplement from conception through
24 months of age had higher high-density lipoprotein
(HDL) cholesterol and lower triglycerides than adults from
the control group.12 In India, adolescents born in villages
where pregnant women and children up to 6 years of age
received a balanced protein-energy supplement, had a
lower occurrence of insulin resistance in comparison with
those in control villages.13 In the Gambia, 11–17-year-old
children born to supplemented mothers had marginally
lower fasting glucose levels.14
Anaemia in pregnancy is common and prenatal supple-
mentation of iron and folic acid has been recommended by
the World Health Organization (WHO) for many years to
address this problem. As women in low-income settings
often suffer from multiple micronutrient deficiencies,15
supplements containing multiple micronutrients including
iron, folic acid and vitamin B12 have been developed and
increasingly been used.16 A large number of trials have
evaluated their short-term effects and systematic reviews
have found significant effects mainly on maternal anaemia
and offspring size at birth.17,18 Little is known about long-
term metabolic consequences of such prenatal supple-
ments. A trial in Nepal did not find any effect of prenatal
multiple micronutrients on blood lipids, glucose, insulin or
homeostasis model assessment (HOMA) in children aged
6–8 years compared with controls. 19
In malnourished populations, pregnant women may
need both energy and protein supplements as well as
micronutrient supplementation. Very few trials have been
designed to evaluate whether combining supplementation
of micro- and macronutrients confers health benefits.
Further, the outcomes for the offspring of nutritional
modification appear to depend on the stage of fetal
Key Messages
• Invitation to food supplementation in early pregnancy (as compared with later) was associated with lower cholesterol,
LDL and ApoB levels of the child at 4.5 years of age
• Supplementation with multiple micronutrients (as compared with standard iron-folate) was associated with lower
HDL, lower glucose and lower IGF-1 levels.
• Nutrition interventions during pregnancy, when plasticity is great, may modify the metabolic phenotype in the young
child.
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development and the vulnerability of the fetus.20 Data
from the Dutch Hunger Winter show that the influence on
the fetus depends on the timing of nutrient restriction in
pregnancy.21 Size at birth is at least partly associated with
fetal size already in the first trimester.22 The Dutch Famine
studies also indicate that nutritional insults in early preg-
nancy may affect metabolic regulatory mechanisms with
negative consequences in adulthood, without effects on
birthweight.23
The MINIMat (Maternal and Infant Nutrition
Interventions in Matlab) trial in Bangladesh evaluated treat-
ment with prenatal multiple micronutrients, including iron
and folic acid, combined with early invitation to food sup-
plementation (around week 9 of gestation), vs a standard
programme that included treatment with iron and folic acid
and usual timing of invitation to food supplementation
(around week 20). Primary outcomes were maternal haemo-
globin level at 30 weeks’ gestation, birthweight and infant
mortality. The early invitation to prenatal food supplemen-
tation in combination with multiple micronutrients resulted
in markedly lower infant and under-five mortality,24 but no
differential effects on the other primary outcomes. The co-
hort of children born in the trial has since then continuously
been followed up. The early invitation to food supplements
reduced stunting up to 4.5 years, whereas allocation of mul-
tiple micronutrients resulted in a higher prevalence of stunt-
ing, all observed in boys.25 The supplementation has also
had small effects on blood pressure.26
The aim of this study is to evaluate whether an early
timing of prenatal food supplementation and multiple
micronutrient supplementation (MMS) favourably influ-
ence childhood metabolic phenotype (biomarkers of lipid
and glucose metabolism, inflammation and oxidative
stress) and if a combination of these interventions further
enhances these outcomes.
Methods
Study location and population
The MINIMat trial was conducted in Matlab sub-district,
located in poor communities in rural Bangladesh. The
International Centre for Diarrhoeal Disease Research,
Bangladesh (icddr,b) runs a Health and Demographic
Surveillance System (HDSS) in a population of 220 000 in
this area. As part of the HDSS activities, community health
workers perform monthly household visits and collect
demographic and health data. This surveillance was used
to identify and enrol pregnant women over a 2-year period.
Eligibility criteria for participation were a viable fetus, ges-
tational age less than 14 weeks by ultrasound examination,
no severe illness and written consent. A previous report has
described the MINIMat trial in detail.24
This follow-up of the MINIMat trial included recruit-
ments that took place during one of the two full calendar
years of recruitment to the trial. Children born to the 2119
pregnant women, who were enrolled in the MINIMat trial
from 1 January 2002 to 31 December 2002, were selected
for biomarker analyses at 4.5 years of age. Only children
who had anthropometric measurements at birth were eli-
gible for this follow-up (n¼ 1667), whereof 1354 children
participated in blood sampling at 4.5 years. We randomly
selected smaller subsets for analyses of growth factors and
oxidative stress markers (Figure 1).
Study design and interventions
Women had been individually and randomly allocated
(2 by 3 factorial design) to two food groups and three
micronutrient groups resulting in six groups in total
(Figure 1). The food supplement consisted of a powder
made of roasted rice, roasted pulse, molasses and soybean
oil, to be mixed with water. This was provided at commu-
nity nutrition centres 6 days per week, giving 608 kcal of
energy per day. The two food supplement groups were
invited to start supplementation either (i) immediately after
detection of pregnancy, usually around pregnancy week 9
(early timing of invitation), or (ii) at the time of their
choice, usually around pregnancy week 20 (usual timing of
invitation, i.e. standard care). The three types of micronu-
trient supplements were capsules containing either: (i)
30 mg of iron (fumarate) and 400lg folic acid (Fe30F); or
(ii) 60 mg iron and 400lg folic acid (Fe60F); or (iii) mul-
tiple micronutrients (MMS)16 containing 30 mg of iron,
400lg of folic acid, 800lg of RE vitamin A (retinyl acet-
ate), 200 IU of vitamin D (D3), 10 mg of vitamin E (a-toc-
opherol acetate), 70 mg of vitamin C, 1.4 mg of vitamin B1
(thiamine mononitrate), 1.4 mg of vitamin B2 (riboflavin),
18 mg of niacin, 1.9 mg of vitamin B6 (pyridoxine hydro-
chloride), 2.6 lg of vitamin B12 (cyanocobalamin), 15 mg
of zinc (sulphate), 2 mg of copper (sulphate), 65lg of sel-
enium (sodium selenite) and 150lg of iodine (potassium
iodide). The women received the micronutrients in a bottle
at health clinics in gestational week 14. There was a
monthly refill of bottles.
Outcomes
The primary outcomes were maternal haemoglobin at 30
weeks of gestation, birthweight and infant mortality.24
Secondary outcomes reported in this paper are metabolic
markers (lipid and glucose metabolism, inflammation, oxi-
dative stress) at 4.5 years of age. Other secondary
1658 International Journal of Epidemiology, 2016, Vol. 45, No. 5
outcomes include psychomotor development in infancy,27
effect on micronutrient status in infancy,28 immune func-
tion,29,30 childhood growth31 and body composition at 4.5
years of age.32
Data collection
Pregnancy and delivery
At approximately gestational week 8, information was col-
lected through household visits on household assets and
was compiled into an asset score, in addition to women’s
health, pregnancy history and attained level of education.
Trained personnel took anthropometric measurements at
week 8 at the first health clinic visit. Body Mass Index
(BMI) was calculated by dividing the weight (kg) by the
height squared (m2). Through a birth notification system,
anthropometric data of the newborns were collected
within 72 h. Maternal use of food supplements was as-
sessed by repeated 4-week recall collected at household vis-
its. Adherence to micronutrient supplementation was
monitored by an electronic device, eDEMV
R
, recording each
opening of the capsule bottle and used as an indicator of
supplement adherence.
Follow-up of children at 4.5 years
Trained nurses took anthropometric measurements of the
children at health clinics. Paramedics collected overnight
fasting blood samples of 5 ml venous blood using Li-
heparin-treated trace-element-free tubes (Sarstedt
MonevetteV
R
, Uppsala, Sweden). The plasma was centri-
fuged, separated within 4 h and stored at -70C freezers at
the laboratory in Matlab hospital. Urinary samples were
collected in cups, transferred to plastic vials and trans-
ported cold to the laboratory where they were frozen and
stored in -70C. Plasma and urine samples were shipped
on dry ice to Uppsala University, Sweden, for biomarker
analysis.
Glucose was analysed in whole blood at the field site
health clinics by HemoCueV
R
(HemoCue, €Angelholm,
Sweden). Plasma apolipoprotein A-1 (ApoA1), apolipopro-
tein B (ApoB), cholesterol, HDL, LDL, triglycerides and
C-reactive protein (CRP) were measured by immunotur-
bidimetry on the Architect ci8200V
R
Analyzer (Abbott
Diagnostics). Plasma insulin was analysed by an immuno-
logical sandwich technique using ModularV
R
Analytics E
170 Module (Roche Diagnostics). Insulin resistance was
estimated by the homeostasis model assessment (HOMA-
IR) [HOMA-IR ¼ fasting plasma insulin level (mU/l 
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Figure 1. Flow-chart of participating women and children.
International Journal of Epidemiology, 2016, Vol. 45, No. 5 1659
fasting plasma glucose level (mmol/l)/22.5].33 The coeffi-
cient of variation (CV) was measured at two levels and for
the lipid biomarkers CV was  3% in all cases. For CRP,
the CV was  5% and for insulin 4%. IGF-1 in plasma
was determined by radioimmunoassay after separation of
IGF-1s from insulin growth factor BP 1 (IGFBP-1) by acid–
ethanol extraction and cryoprecipitation.34 IGFBP-1 was
analysed using radioimmunoassay as described by Povoa
et al.35). 8-iso-PGF2a, a major F2-isoprostane and a reliable
marker of oxidative stress in vivo, was analysed in urine
samples in Uppsala, Sweden, by a validated radioimmuno-
assay developed by Basu.36
Concentrations of CRP were below the detection limit
of the assay (0.20 mg/l) in 24% of the plasma samples. All
these samples were assigned half the value of the detection
limit, i.e. 0.10 mg/l, to use as estimates in statistical ana-
lyses. Similarly, 7% of insulin samples were below the
assay’s detection limit (0.20 mU/l) and were thus assigned
half the value of the detection limit, 0.10 mU/l. The distri-
bution of children with concentrations below the detection
limit was tested across food and supplementation groups.
We found no difference in the frequency of being below
the detection limit for either CRP or insulin concentrations
depending on supplementation group. Further, for com-
parisons all key analyses were also performed in a subset
of children with CRP above detection limit but, since there
was no major difference in results if these were included or
not, all are included in the presented results.
Randomization
Enrolled women were individually randomized into one of
the six intervention groups by a computer-generated regis-
ter of study identification numbers in permuted blocks of
12. Research staff and participating women were blinded
for type of micronutrient supplementation and micronu-
trient capsules and bottles were identical. Invitation to
food supplementation was randomly allocated but not
blinded by design. Randomization codes were kept safe
and confidential at icddr,b.
Sample size
The original sample size calculations were based on birth-
weight as one of the primary outcomes. A difference of
70 g was considered to be the minimum important group
difference. With 90% power and a type I error of 0.05, the
total sample size required was 5300 women with adjust-
ments for 5% refusal, 11% loss during pregnancy and 9%
out-migration. This paper reports the secondary outcome
metabolic status assessed by biomarker concentrations in a
subset of children at 4.5 years of age. For analyses of lipids,
CRP, glucose and insulin, all children to mothers enrolled
during 1 calendar year were chosen to be able to cover pos-
sible seasonal differences. We used the anticipated number
of children expected for biomarker analyses (n¼ 1414) to
calculate the effects we would be able to detect according
to the design of the trial. The effect sizes were expressed as
a difference in standard deviation (SD) applying 95% con-
fidence and 80% power. We would be able to detect a
0.16 z-score difference in any biomarker across two nutri-
tional supplementation groups (i.e. early invitation to food
supplementation vs usual timing) or a 0.48 z-score differ-
ence across the six food and micronutrient supplementa-
tion groups. For growth factors and markers of oxidative
stress, smaller randomly selected subsets from the same
calendar year were used. For those analyses, a sample of
600 children would enable a detection of 0.23 z-score dif-
ference between two nutritional supplementation groups
or a 0.69 z-score difference across the six supplementation
groups.
Statistical analysis
Baseline descriptive characteristics were compared be-
tween individuals with complete (included in main ana-
lyses) and incomplete data, and across intervention groups.
The primary outcome was biomarker concentration in
children at 4.5 years of age and analyses were by intention-
to-treat. Biomarkers were presented in blocks divided into
lipid metabolism (apoA1, apoB, apoB/apoA1, cholesterol,
HDL, LDL, LDL/HDL, triglycerides), glucose metabolism
(glucose, insulin, HOMA-IR), growth factors (IGF-1,
IGFBP-1, IGF-1/IGFBP-1), inflammation (CRP) and oxida-
tive stress (8-iso-PGF2a).
Normally distributed biomarkers are presented as
means with 95 % confidence intervals (all assessed lipid
markers and glucose). Non-normally distributed bio-
markers are presented as medians with interquartile ranges
(insulin, HOMA-IR, 8-iso-PGF2a, CRP and IGF-1, IGFBP-
1, IGF-1/IGFBP-1). Non-normally distributed biomarkers
were transformed to the natural logarithm before analyses.
Due to the proportion of cases having a CRP below detec-
tion level (0.20 mg/l), we performed an additional analysis
only including children with detectable CRP using log
transformation. There was no association between the
interventions and CRP levels using this exclusion (data not
shown).
Differences between categorical variables were assessed
by Pearson’s chi-square test. Independent two-sample
t-tests and analysis of variance (ANOVA) were used in the
case of continuous variables to compare group differences
(presented as differences of means). According to the ori-
ginal study protocol and study hypotheses, biomarkers of
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children born into the MMS supplement group were com-
pared with the standard of micronutrient care provided in
the Fe60F group. Biomarker concentrations in the Fe30
group are presented for descriptive purposes, although that
intervention group mainly was motivated in relation to the
primary outcome haemoglobin at 30 weeks of gestation.
The early timing of food supplementation was compared
with the standard of care, i.e. usual timing. As stated in the
study protocol, and seeing that an important interaction
between food and micronutrient supplementation groups
has been observed previously,24 we evaluated the inter-
action between food and micronutrient supplementation
groups according to the 2 x 3 factorial design of the trial at
P< 0.05.
Due to the possibility of a biased selection of individuals
lost to follow-up, we performed additional analyses con-
trolling for potential confounding factors, although the
study design is a randomized controlled trial. We per-
formed analyses including the variables of maternal height,
maternal BMI at recruitment (around gestational week 9),
socioeconomic status of the household (represented by
asset score), child age and child sex. The inclusion of any
of these variables only caused minor changes to the effect
estimates and made no difference to the interpretation of
results. We are therefore only presenting the crude effect
estimates.
Sex differences have been reported previously from this
cohort31 and also suggested in related literature.37,38 Thus,
regardless of whether any significant interactions between
interventions and sex on the different outcomes were
found, we present additional analyses stratified for sex of
child in supplementary tables (available as Supplementary
data at IJE online).
Analyses were done using the IBM SPSS Statistics 20.0
(SPSS Inc., Chicago, IL, USA).
Ethical considerations
Informed consent was obtained from the participating
women for the original trial and each step in the child
follow-up. The study was approved by the ethical review
committee at icddr,b, and the 4.5-year follow-up including
analyses of metabolic biomarkers was approved by the re-
gional ethical review board at Uppsala University, Sweden.
Table 1. Descriptive characteristics of women and children by complete and incomplete data and by food and micronutrient
supplementation groupsa
Maternal food supplementation Maternal micronutrient supplementation
Complete
(n¼1351)
Incomplete
(n¼316)
Early invitation
(n¼682)
Usual invitation
(n¼669)
MMS
(n¼439)
Fe60F
(n¼454)
Fe30F
(n¼458)
Household SES quintiles
(% living in quintiles)b
Lowest quintile 298 (22) 63 (20) 156 (23) 142 (21) 101 (23) 104 (23) 93 (20)
Highest quintile 243 (18) 79 (25) 119 (17) 124 (19) 78 (18) 75 (17) 90 (20)
Maternal characteristics
pregnancy week 8
Age (years) 26.7 (5.9) 26.1 (5.8) 26.7 (6.1) 26.7 (5.8) 26.7 (5.9) 26.5 (6.1) 26.8 (5.8)
Height (cm) 149.8 (5.3) 149.8 (5.3) 150.1 (5.3) 149.6 (5.4) 149.9 (5.5) 149.9 (5.1) 149.7 (5.4)
BMI (kg/m2) 19.9 (2.6) 20.2 (2.7) 19.9 (2.6) 20.0 (2.6) 20.1 (2.7) 19.8 (2.6) 19.8 (2.6)
Parityc
0 402 (30) 126 (40) 210 (31) 192 (29) 129 (29) 143 (32) 130 (28)
1 358 (27) 84 (27) 170 (25) 188 (28) 122 (28) 113 (25) 123 (27)
 2 591 (44) 106 (34) 302 (44) 289 (43) 188 (43) 198 (44) 205 (45)
Schooling (years)
0 500 (37) 90 (29) 256 (38) 244 (37) 173 (39) 160 (35) 167 (37)
1–4 139 (10) 44 (14) 73 (11) 139 (10) 47 (11) 42 (9) 50 (11)
 5 712 (53) 182 (58) 353 (52) 359 (54) 219 (50) 252 (56) 241 (53)
Child characteristics
Male sex 709 (53) 161 (51) 360 (53) 349 (52) 229 (52) 237 (52) 243 (53)
Age (months) 54.4 (1.7) 54.8 (2.3) 54.3 (1.7) 54.5 (1.8) 54.4 (1.7) 54.4 (1.7) 54.5 (1.8)
Weight (kg) 13.7 (1.6) 14.3 (2.1) 13.7 (1.5) 13.7(1.7) 13.6 (1.5) 13.7 (1.6) 13.8 (1.7)
Height (cm) 99.5 (4.4) 100.3 (5.6) 99.6 (4.3) 99.4 (4.5) 99.3 (4.4) 99.5 (4.3) 99.8 (4.5)
aData are presented as number (%) or mean (SD).
bSignificantly different from incomplete with chi-square test, P¼ 0.017.
cSignificantly different from incomplete with chi-square test, P¼ 0.001.
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Results
The number of women lost to follow-up did not differ
across the supplementation groups. Women with complete
data had a higher percentage in the highest household asset
score quintile and had more previous births as compared
with women with incomplete data (Table 1).
Women were short and lean, with approximately one-
third having BMI< 18.5 kg/m2 and one-third being illiter-
ate. There were no differences in baseline characteristics
across supplementation groups. At 4.5 years of follow-up,
boys had a mean weight of 14.0 kg (SD 1.6) or weight-for-
age Z-score (WAZ) -1.36, mean height of 100.2 cm (SD
4.5) or height-for-age Z-score (HAZ) -1.46 and 31% were
stunted (HAZ-score<-2.0). Girls had a mean weight of
13.4 kg (SD 1.6) or WAZ -1.38, a mean height of 98.9 cm
(SD 4.3) or HAZ -1.60 and 36% were stunted.
By design, those women allocated to the early invitation
to food supplementation consumed more packages of sup-
plements than those allocated to the usual timing of invita-
tion (mean difference 30 packages from enrolment to week
30 examination). On average the women took 77 micronu-
trient capsules and the MMS group took slightly fewer
capsules (75) than the other groups.
Effects of timing of prenatal food supplementation
Children whose mothers had been allocated to early food
supplementation had significantly lower apoB, lower chol-
esterol and lower LDL levels than children born to
mothers allocated to food supplements with the usual tim-
ing (Table 2). In sex-stratified analyses, the overall effects
on apoB, cholesterol and LDL were found in boys
(Supplementary Table 1, available as Supplementary data
at IJE online).
We found no differential effect by timing of food sup-
plementation groups on markers of glucose metabolism
(Table 2). Allocation to timing of food supplementation
had no effect on the assessed child growth factors (Table
2). There were no associations between timing of food sup-
plementation and child inflammation marker (assessed by
plasma CRP) or marker of oxidative stress (assessed by
urinary 8-iso-PGF2a) (Table 2). There was no interaction
between the food and micronutrient groups for any of the
biomarkers.
Effects of prenatal micronutrient supplementation
Children born to women allocated to MMS had signifi-
cantly lower HDL than children with mothers randomized
to Fe60F (Table 2). We found no other differences in lipid
concentrations related to maternal micronutrient group.
Allocation to prenatal MMS supplementation resulted in
lower fasting glucose concentrations in the children com-
pared with the Fe60F group (Table 2). In sex-stratified
analyses, this was only found among boys (Supplementary
Table 2, available as Supplementary data at IJE online).
Overall insulin concentrations were relatively low, but
MMS supplementation had no differential effect on the
child’s fasting insulin concentration at 4.5 years. Children
whose mothers had been allocated to the MMS group
had lower IGF-1, corresponding to 14% difference in me-
dian, higher IGFBP-1 and consequently lower IGF-1/
IGFBP-1 ratio compared with children from the Fe60F
group (Table 2). In sex-stratified analyses, this association
was only observed in boys with higher IGFBP-1 and lower
IGF-1/IGFBP-1 concentrations (Supplementary Table 2).
There were no associations between type of micronutrient
supplement with the child CRP or urinary 8-iso-PGF2a
concentrations (Table 2).
Discussion
This trial was performed in a population where maternal
and child chronic undernutrition is prevalent. An early
start of food supplementation during pregnancy, when
plasticity is great, influenced the metabolic phenotype at
4.5 years with a more favourable lipid profile. Children of
women allocated to multiple micronutrient supplementa-
tion (as compared with standard iron-folate) had lower
levels of fasting glucose and insulin-like growth factor 1
and also lower levels of HDL. The combination of the dif-
ferent food and micronutrient alternatives did not further
enhance these effects.
We report on of the secondary outcomes of a prenatal in-
dividually randomized controlled trial with a follow-up of
the offspring to the age of 4.5 years. We found small differ-
ences between women with complete vs incomplete data,
where those included in the analyses had higher household
asset scores (wealth) and more children. There was no asso-
ciation between participation and intervention groups. This
implies that the results presented should not be influenced
by any selection bias. Additional analyses were also per-
formed controlling for potential confounders, without any
important changes of effect estimates. All data collection
followed standard operating procedures, and appropriate
refresher training was conducted throughout the study
period. The Matlab area, as well as other parts of the delta
region in Bangladesh, has varying levels of arsenic contam-
ination of drinking water from tube wells. There was no as-
sociation between drinking water arsenic levels and the
MINIMat randomized interventions,39 which implies that
arsenic exposure could not confound the reported associ-
ations between interventions and metabolic markers.
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Lipid metabolism
The DOHaD hypothesis implicitly suggests that improving
the nutritional status of malnourished mothers may have
favourable effects on the metabolic phenotype of the child
and influence later risks for chronic diseases. Bangladesh is
undergoing a rapid nutritional and epidemiological transi-
tion, and has reportedly very high population-based preva-
lence of metabolic syndrome,40 type 2 diabetes41 and
insulin resistance.42 We consistently found that children
born to women who had been invited to an early start of
food supplementation in pregnancy, had a more favourable
lipid profile at 4.5 years, such as lower apoB, cholesterol
and LDL cholesterol. Effect sizes were relatively small
(2–3%). In boys alone, the differences between supplemen-
tation groups were slightly higher (3–4%) and this is of
similar size as the effects of the STRIP trial in Finland,
where dietary counselling regarding low-fat food initiated
in infancy resulted in 2–6% lower serum lipids (apoB,
cholesterol and HDL) as compared with controls at 5 years
of age.43 In spite of the relatively small effect sizes, such
differences may constitute risk indicators for future meta-
bolic trajectories with long-term health consequences.
Our study differs from the previously mentioned protein-
energy supplementation trials12,14 in that the food supple-
mentation was available to all women but the timing of the
start of supplementation was randomized. Nutritional con-
straints in fetal life may have different effects depending on
when they occur. The importance of timing of nutritional
insults has been observed in animal models.20 In ecological
studies such as the Dutch Famine research, it has been
shown that placenta development and function differ ac-
cording to whether exposure to famine was in early, mid or
late gestation.44 Undernourished women starting food sup-
plementation around gestational week 9 in the early invita-
tion group may have benefited from the improved balanced
food intake, resulting in developmental adaptations and per-
manent metabolic changes for the fetus in this period of
early organogenesis and rapid growth.45
Women included in this trial had a high prevalence of
several micronutrient deficiencies when assessed at base-
line in early pregnancy,46 including vitamin B12 and zinc
deficiencies. These micronutrients were provided in the
multiple micronutrient supplements. Women in the MMS
group had significantly lower HDL, indicative of an un-
favourable effect. No such effects on lipids were found in
the Nepal trial that included multiple micronutrient sup-
plements and allocated vitamin A only as control.19
Glucose metabolism
Children of mothers receiving MMS had significantly
lower fasting glucose levels as compared with those
allocated to the standard Fe60F. A lower fasting blood glu-
cose may be indicative of a favourable effect of maternal
multiple micronutrients. Average fasting glucose levels of
these children were within the normal range, comparable
with healthy children in Finland47 and India,48 and slightly
higher than those reported from Nepalese children.19
The average insulin levels were low, which conse-
quently also was reflected in low HOMA-IR. The observed
insulin levels had a median value around the lower 25th
percentile of children in both Nepal19 and India.48 Animal
models of protein restriction during pregnancy have shown
changes in pancreatic islets resulting in impaired insulin se-
cretion in the offspring.49 We did not find any major differ-
ential effects of food or micronutrient supplementations on
insulin or HOMA-IR. In India, adolescents born to preg-
nant mothers who received food supplements, had lower
insulin resistance compared with controls.13
Growth factors
Levels of IGF-1 vary widely in healthy children depending
on age, sex and stage of puberty.50 However, our observed
IGF-1 concentrations were low, approximately 35% lower
than those reported in healthy Danish children in the same
age group.51 IGF-1 levels are affected by current nutri-
tion,52 and protein and energy restriction has been associ-
ated with lower IGF-1 in humans. As previously reported,
31% of the children were stunted at 4.5 years,25 and our
observations of low IGF-1 concentrations may be a reflec-
tion of poor nutrition and of potential concern for these
growing children.
We found that micronutrient supplementation in preg-
nancy was associated with the assessed growth factors.
IGF-1 was lower in children of mothers receiving multiple
micronutrients in pregnancy compared with the standard
treatment with Fe60F which, in consideration of their gen-
erally low IGF-1 levels, may be considered unfavourable.
As a crude measure of biologically active IGF-1, the IGF-1/
IGFBP-1 ratio supports this interpretation. We have previ-
ously reported that children of mothers who were allocated
to MMS more frequently were stunted in infancy and
childhood up to 4.5 years of age.25 This matches our find-
ing of MMS and IGF-1 levels. In a primate model, mater-
nal undernutrition during pregnancy was associated with
reduced IGF-1 levels in the fetus,53 and in humans, reduced
IGF-1 levels were observed in children growth-restricted in
utero compared with normal children.54 This suggests an
adaptive response of IGF-1 to nutrition in fetal life. In our
study, we also observed higher IGFBP-1 levels in the chil-
dren whose mothers were allocated to MMS. As IGFBP-1
is a marker of insulin sensitivity,55 this suggests a poten-
tially reduced future risk of CVD. In a Swedish study, adult
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women born small for gestational age were shorter and
had lower IGFBP-1 levels compared with full-term con-
trols, suggesting reduced growth together with relative in-
sulin resistance.56 In our studied children, however, lower
IGF-1 and stunted growth were accompanied by higher
IGFBP-1. Our results indicate that the growth factors IGF-
1 and IGFBP-1 in the children were modified by maternal
micronutrient supplements, but the mechanisms are
unclear.
Conclusion
This trial was performed in a population where chronic
malnutrition still is common among mothers and children,
and where rapid epidemiological and nutrition transitions
take place. An early start of food supplementation during
pregnancy influenced the metabolic phenotype at 4.5 years
with a more favourable lipid profile. Children of mothers
allocated to multiple micronutrient supplementation had
lower levels of fasting glucose and IGF-1 but also lower
levels of HDL. These findings suggest that nutrition inter-
ventions during pregnancy when plasticity is great may
modify the metabolic phenotype in the young child, which
could have consequences for later chronic disease risks.
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